Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: an animal model.

Hou JC, Landas S, Wang CY, Shapiro O.

Anticancer Res. 2011 Mar;31(3):929-32.

PMID:
21498715
[PubMed - indexed for MEDLINE]
2.

Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection.

Shapiro O, Jones K, Wang C, Landas S, Haas GP.

Can J Urol. 2006 Dec;13(6):3317-20. Review.

PMID:
17187694
[PubMed - indexed for MEDLINE]
3.

Perivesical inflammation and necrosis due to mitomycin C instillation after transurethral resection of bladder tumor: we must be vigilant!

Fazlioglu A, Tandogdu Z, Kurtulus FO, Parlakkilic O, Cek M.

Urol Int. 2009;83(3):362-3. doi: 10.1159/000241684. Epub 2009 Oct 13.

PMID:
19829042
[PubMed - indexed for MEDLINE]
4.

[Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder].

Isbarn H, Budäus L, Pichlmeier U, Conrad S, Huland H, Friedrich MG.

Urologe A. 2008 May;47(5):608-15. doi: 10.1007/s00120-008-1671-z. German.

PMID:
18317718
[PubMed - indexed for MEDLINE]
5.

Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C.

Verma A, Degrado J, Hittelman AB, Wheeler MA, Kaimakliotis HZ, Weiss RM.

BJU Int. 2011 Apr;107(7):1154-61. doi: 10.1111/j.1464-410X.2010.09543.x. Epub 2010 Aug 24.

PMID:
20735383
[PubMed - indexed for MEDLINE]
7.

[5 years intravesical instillation with mitomycin-C and pirarubicin as a prophylactic treatment for superficial bladder cancer].

Kobayashi S, Oka K, Machida T, Ishizaka K.

Nihon Hinyokika Gakkai Zasshi. 2006 May;97(4):636-41. Japanese.

PMID:
16768144
[PubMed - indexed for MEDLINE]
Free Article
8.

Increasing medical staff safety by using a closed system for intravesical instillation of mitomycin C.

Haifler M, Lang E, Sabler I, Gutman Y, Lindner A, Zisman A.

Urology. 2010 Sep;76(3):649-51. doi: 10.1016/j.urology.2010.02.058. Epub 2010 May 20.

PMID:
20493518
[PubMed - indexed for MEDLINE]
9.

Continuous saline bladder irrigation after transurethral resection is a prophylactic treatment choice for non-muscle invasive bladder tumor.

Onishi T, Sasaki T, Hoshina A, Yabana T.

Anticancer Res. 2011 Apr;31(4):1471-4.

PMID:
21508405
[PubMed - indexed for MEDLINE]
11.

Effect of intraurethral Mitomycin-C on healing and fibrosis in rats with experimentally induced urethral stricture.

Ayyildiz A, Nuhoglu B, Gülerkaya B, Caydere M, Ustün H, Germiyanoglu C, Erol D.

Int J Urol. 2004 Dec;11(12):1122-6.

PMID:
15663686
[PubMed - indexed for MEDLINE]
12.

Single instillation of mitomycin C reduces 1st year recurrence following transurethral resection of non-muscle invasive bladder cancer.

Ather MH, Aziz S, Sulaiman MN.

J Ayub Med Coll Abbottabad. 2007 Oct-Dec;19(4):18-20.

PMID:
18693589
[PubMed - indexed for MEDLINE]
13.

Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer.

Mostafid AH, Rajkumar RG, Stewart AB, Singh R.

BJU Int. 2006 Mar;97(3):509-12.

PMID:
16469017
[PubMed - indexed for MEDLINE]
14.

Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study.

Ersoy H, Yaytokgil M, Karakoyunlu AN, Topaloglu H, Sagnak L, Ozok HU.

Drug Des Devel Ther. 2013;7:1-6. doi: 10.2147/DDDT.S39541. Epub 2012 Dec 28.

PMID:
23300343
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A comparative study of the inhibiting effects of mitomycin C and polyphenolic catechins on tumor cell implantation/growth in a rat bladder tumor model.

Selman SH, Keck RW.

J Urol. 2011 Aug;186(2):702-6. doi: 10.1016/j.juro.2011.03.125. Epub 2011 Jun 17.

PMID:
21683410
[PubMed - indexed for MEDLINE]
16.

Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumor.

Maeda T, Kikuchi E, Matsumoto K, Miyajima A, Oya M.

J Urol. 2011 Mar;185(3):802-6. doi: 10.1016/j.juro.2010.10.081. Epub 2011 Jan 15.

PMID:
21239010
[PubMed - indexed for MEDLINE]
17.

Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat bladder tumor model.

Jankun J, Keck RW, Selman SH.

Int J Oncol. 2014 Jan;44(1):147-52. doi: 10.3892/ijo.2013.2174. Epub 2013 Nov 13.

PMID:
24220494
[PubMed - indexed for MEDLINE]
18.

[Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].

Mauroy B, Bonnal JL, Prevost B, Chive M, Lhotellier V, Sozanski JP, Vanseymortier L, Stefaniak X.

Prog Urol. 1999 Feb;9(1):69-80. French.

PMID:
10212955
[PubMed - indexed for MEDLINE]
19.

Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer.

Tsushima T, Matsumura Y, Ozaki Y, Yoshimoto J, Ohmori H.

Cancer Chemother Pharmacol. 1987;20 Suppl:S72-6.

PMID:
3117400
[PubMed - indexed for MEDLINE]
20.

Influence of intraperitoneal therapy with mitomycin C adsorbed on activated carbon on anastomotic and wound healing in rats.

Jansen M, Jansen PL, Fass J, Langejürgen E, Forsch S, Tietze L, Schumpelick V.

Dig Dis Sci. 2002 Sep;47(9):1992-7.

PMID:
12353843
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk